'Citalopram' presentation slideshows

The Impact of Co-existing Chronic Pain and Mental Health QUERI Conditions: QUERI Implementation Seminar Series

The Impact of Co-existing Chronic Pain and Mental Health QUERI Conditions: QUERI Implementation Seminar Series. Matthew J. Bair, MD, MS Research Scientist, Roudebush VA Center of Excellence on Implementing Evidence Based Practice and Regenstrief Institute, Inc

886 views • 58 slides

Cardiac Psychiatry: Review and Updates

Cardiac Psychiatry: Review and Updates. Scott R. Beach, MD, FAPM Avery D. Weisman Psychiatric Consultation Service Program Director, Adult Psychiatry Residency Massachusetts General Hospital MGH Cardiac Psychiatry Research Group Assistant Professor in Psychiatry, Harvard Medical School

1.03k views • 47 slides

Prevalence of Anxiety Disorders

Prevalence of Anxiety Disorders. Kessler et al. Arch Gen Psychiatry . 1995;52:1048. Kessler et al. Arch Gen Psychiatry . 1994;51:8. Outcome of Panic Disorder at Long-Term Follow-up. Roy-Byrne & Cowley, 1995. Pharmacopoeia for Anxiety Disorders. Antidepressants

1k views • 37 slides

ANXIETY DISORDERS

ANXIETY DISORDERS. Dr David Schaefer. History Normal anxiety: - evolutionary - alerting signal - interpersonal Pathological: - most common - selective attention - Yerkes Dobson. Classification. Generalised anxiety disorder

335 views • 21 slides

Experiences gained through the Environmental Classification System for Pharmaceuticals Andreas Woldegiorgis, Ph. D.

Experiences gained through the Environmental Classification System for Pharmaceuticals Andreas Woldegiorgis, Ph. D. Conference on Sustainable Development and Pharmaceuticals, Uppsala 10-11/11, 2009. Overview. Background The PEC/PNEC relationship PEC and human metabolism

248 views • 17 slides

THE UK EXPERIENCE RELATED TO ESCITALOPRAM

289 views • 17 slides

Best Practice Guide: Treatment and care for behavioural and psychological symptoms

271 views • 13 slides

A Population PK Model For Citalopram And Its Major Metabolite, N- desmethyl Citalopram, In Rats

A Population PK Model For Citalopram And Its Major Metabolite, N- desmethyl Citalopram, In Rats. Nieves Velez de Mendizabal 1, 2 , Kimberley Jackson 3 , Brian Eastwood 4 , Steven Swanson 5 , David M. Bender 5 , Stephen Lowe 6 , Robert R. Bies 1, 2.

193 views • 1 slides